Pancreatic beta cells (β-cells) are the only cells that can produce insulin, and a significant cause of diabetes is a reduction in these cells
Healthcare & Pharmaceuticals
An approval which can transform the treatment technology for β-thalassemia and sickle-cell disease
Intratumoral therapy, in which cancer drugs are injected directly into tumors
A University of Alberta team has developed a new step to improve the process for creating insulin-producing pancreatic cells from a patient’s own stem cells, bringing the prospect of injection-free treatment closer for people with diabetes.
Researchers at the University of Cambridge have proven that a simple blood test is enough for the diagnosis of bipolar disorder. They used a combination of online psychiatric assessments and blood tests to diagnose patients with bipolar disorder.
With the advancement of stem cell technology and 3D printing, researchers at the University of Oxford developed a 3D printing method for the purpose of repairing brain injuries. It was initially tested in mouse brain fragments, to this the implant was attached. These implants then got integrated with the mouse brain fragments. This newly developed technology can be used for curing lethal brain injuries.
Antibiotics are common agents used in modern healthcare that are used against certain microbial infections. Antibiotics are compounds that fight infections caused by bacteria in humans and animals. They have undoubtedly transformed the world and have certainly contributed to increasing human life expectancy by treating several life-threatening infectious diseases by the administration of antibiotics.
Moderna’s new mRNA (messenger Ribonucleic Acid) flu shot completed the phase 3 trials with succeeding data. They are aiming to launch in early 2024. The flu vaccine – mRNA-1010 has produced an immune response against all four A and B strains – A/H1N1, A/H3N2, influenza B/Yamagata, and B/Victoria.
Bayer confirms the positive results of their Parkinson’s stem cell therapy initial trial developed by their subsidiary BlueRock Therapeutics. The trial was conducted on 12 patients which shows signs of reducing the Parkinson’s disease symptoms. Earlier, Bayer announced the success of the trial but the details were withheld. “Bayer AG […]
The new variant of COVID-19 was initially found in Denmark on July 24 in a patient with severe symptoms and gradually found in other symptomatic patients during sample testing and screening.
